After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?
Year of publication: |
2019
|
---|---|
Authors: | Aboy, Mateo |
Other Persons: | Liddicoat, John (contributor) ; Liddell, Kathleen (contributor) ; Jordan, Matthew (contributor) ; Crespo, Cristina (contributor) |
Publisher: |
[2019]: [S.l.] : SSRN |
Subject: | Patent | Patentrecht | Patent law | Immaterialgüterrechte | Intellectual property rights |
Extent: | 1 Online-Ressource (31 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: 35 Nature Biotechnology 820-825 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments September 11, 2017 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Yamabhai, Inthira, (2013)
-
Patent assertion entities : do they impede innovation and technology commercialisation?
Hemphill, Thomas A., (2014)
-
R&D and patenting by firms in India in high- and medium-high-technology industries
Ambrammal, Sunil Kumar, (2014)
- More ...
-
Liddicoat, John, (2020)
-
Liddicoat, John, (2021)
-
Liddicoat, John, (2021)
- More ...